Anthropic is setting up a wet biology laboratory in the San Francisco Bay Area to conduct physical experiments, according to a Reuters report and confirmations cited by other outlets. The company acknowledges the lab exists, but says it will not provide details on what it is being used for.
In interviews and reporting, Anthropic’s head of life sciences, Eric Kauderer-Abrams, says the work is part of a broader approach that includes real lab testing rather than relying only on computer simulations. He describes the company’s efforts as similar to those of many biotech firms, combining work performed in its own facilities with collaboration through external partners. Korea Times reports Anthropic is also ramping its AI-related drug and treatment ambitions, including a focus on rare diseases.
The differing angles center on how directly the lab connects to drug discovery: one outlet notes Anthropic rules out the most obvious interpretation as drug discovery specifically, while another frames the facility as supporting the company’s AI drug program. Overall, sources agree the lab enables hands-on biology work beyond “in silico” experiments, but Anthropic provides limited public specifics on targets or outputs.
